A phase II single-blind, randomized, placebo-controlled trial to study the efficacy and safety of Study Drug administered as adjunctive treatment to patients with acquired thrombotic thrombocytopenic purpura.
The Challenges of Patient Recruitment in Oncology Trials - Part 1
As the oncology environment continues to grow towards more targeted therapies, it is imperative that patient recruitment strategies focus on how to…
Persistence Leads To High Enrollment
A Phase IV, randomized, single-blind, placebo-controlled, multi-center study to evaluate the immunogenicity of pneumococcal and influenza vaccines in…
PRA in China Biometrics
The expertise of a global CRO + local know-how to deliver the highest caliber of clinical development services around the world.